← Back to All US Stocks

NHTC Stock Analysis 2026 - NATURAL HEALTH TRENDS CORP AI Rating

NHTC Nasdaq Wholesale-Miscellaneous Nondurable Goods DE CIK: 0000912061
Recently Updated • Analysis: Apr 13, 2026 • SEC Data: 2025-12-31
STRONG SELL
85% Conf
Pending
Analysis scheduled

📊 NHTC Key Takeaways

Revenue: $39.8M
Net Margin: -2.2%
Free Cash Flow: $-6.1M
Current Ratio: 2.50x
Debt/Equity: 0.00x
EPS: $-0.08
AI Rating: STRONG SELL with 85% confidence

Is NHTC a Good Investment? Thesis Analysis

Claude

NHTC exhibits deteriorating fundamentals with declining revenue (-7.4% YoY), negative operating cash flow (-$6.0M), and ongoing losses despite strong gross margins. At current burn rates with only $6.8M in cash reserves, the company has insufficient runway without returning to profitability or securing external capital.

Why Buy NHTC? Key Strengths

Claude
  • + Exceptional gross margin of 73.5% indicates strong underlying product economics
  • + Zero long-term debt provides financial flexibility and no solvency risk
  • + Solid liquidity position with 2.50x current ratio and $6.8M cash reserves

NHTC Investment Risks to Consider

Claude
  • ! Negative operating cash flow of -$6.0M annually indicates company is burning cash at unsustainable rate
  • ! Revenue declining 7.4% YoY with operating losses widening, suggesting structural profitability issues
  • ! Minimal capital expenditure ($68K) suggests lack of growth investment or future revenue initiatives
  • ! Less than 1.5 years of cash runway at current burn rate without profitability improvement

Key Metrics to Watch

Claude
  • * Operating cash flow trend - must return to positive to ensure survival
  • * Revenue growth stabilization - need to arrest declining sales trend
  • * Operating margin improvement - path to profitability must be demonstrated

NHTC Financial Metrics

Revenue
$39.8M
Net Income
$-882.0K
EPS (Diluted)
$-0.08
Free Cash Flow
$-6.1M
Total Assets
$38.4M
Cash Position
$6.8M

💡 AI Analyst Insight

Strong liquidity with a 2.50x current ratio provides a solid financial cushion.

NHTC Profitability Ratios

Gross Margin 73.5%
Operating Margin -4.5%
Net Margin -2.2%
ROE -3.8%
ROA -2.3%
FCF Margin -15.2%

NHTC vs Default Sector

How NATURAL HEALTH TRENDS CORP compares to Default sector averages

Net Margin
NHTC -2.2%
vs
Sector Avg 12.0%
NHTC Sector
ROE
NHTC -3.8%
vs
Sector Avg 15.0%
NHTC Sector
Current Ratio
NHTC 2.5x
vs
Sector Avg 1.8x
NHTC Sector
Debt/Equity
NHTC 0.0x
vs
Sector Avg 0.7x
NHTC Sector

Sector benchmarks are approximate industry averages. Actual sector performance may vary.

Is NHTC Overvalued or Undervalued?

Based on fundamental analysis, NATURAL HEALTH TRENDS CORP has mixed fundamental signals relative to the Default sector in 2026.

Return on Equity
-3.8%
Sector avg: 15%
Net Profit Margin
-2.2%
Sector avg: 12%
Revenue Growth
N/A
Year-over-year
Debt/Equity
0.00x
Sector avg: 0.7x

Note: This is a fundamental analysis based on SEC filings. For P/E ratio, price targets, and market-based valuation, consult financial data providers. This is not investment advice.

NHTC Balance Sheet & Liquidity

Current Ratio
2.50x
Quick Ratio
2.35x
Debt/Equity
0.00x
Debt/Assets
39.0%
Interest Coverage
-113.00x
Long-term Debt
N/A

NHTC 5-Year Financial Trend & Growth Analysis

NHTC 5-year financial data: Year 2021: Revenue $62.1M, Net Income $843.0K, EPS $0.07. Year 2022: Revenue $60.0M, Net Income $1.1M, EPS $0.09. Year 2023: Revenue $49.1M, Net Income $313.0K, EPS $0.03. Year 2024: Revenue $43.9M, Net Income $568.0K, EPS $0.05. Year 2025: Revenue $43.0M, Net Income $572.0K, EPS $0.05.
Revenue
Net Income
EPS (right axis)

5-Year Trend Summary: NATURAL HEALTH TRENDS CORP's revenue has declined by 31% over the 5-year period, indicating business contraction. The most recent EPS of $0.05 reflects profitable operations.

NHTC Growth Metrics (YoY)

Revenue Growth
N/A
Year-over-year
Net Income Growth
N/A
Year-over-year
EPS Growth
N/A
Earnings per share
FCF Margin
-15.2%
Free cash flow / Revenue

NHTC Quarterly Performance

Quarterly financial performance data for NATURAL HEALTH TRENDS CORP including revenue, net income, and earnings per share.
Quarter Revenue Net Income EPS
Q3 2025 $9.5M $15.0K $0.00
Q2 2025 $9.8M $15.0K $0.00
Q1 2025 $10.7M $122.0K $0.01
Q3 2024 $10.6M $35.0K $0.00
Q2 2024 $10.5M $38.0K $0.00
Q1 2024 $11.0M $188.0K $0.02
Q3 2023 $10.6M $47.0K $0.00
Q2 2023 $10.5M $38.0K $0.00

Data sourced from SEC EDGAR 10-Q quarterly filings. Figures may represent quarterly or cumulative values.

NHTC Capital Allocation

Operating Cash Flow
-$6.0M
Cash generated from operations
Capital Expenditures
$68.0K
Investment in assets
Dividends Paid
$9.2M
Returned to shareholders

NHTC SEC 10-K & 10-Q Filing Analysis

Access official SEC EDGAR filings for NATURAL HEALTH TRENDS CORP (CIK: 0000912061)

📋 Recent SEC Filings

Date Form Document Action
Mar 24, 2026 DEF 14A nhtc20251031_def14a.htm View →
Mar 24, 2026 DEF 14A nhtc20251031_def14a.htm View →
Feb 20, 2026 10-K nhtc20251231_10k.htm View →
Feb 17, 2026 8-K nhtc20260211_8k.htm View →
Feb 4, 2026 8-K nhtc20251113_8k.htm View →

Frequently Asked Questions about NHTC

What is the AI rating for NHTC?

NATURAL HEALTH TRENDS CORP (NHTC) has an AI rating of STRONG SELL with 85% confidence, based on fundamental analysis of SEC EDGAR filings.

What are NHTC's key strengths?

Claude: Exceptional gross margin of 73.5% indicates strong underlying product economics. Zero long-term debt provides financial flexibility and no solvency risk.

What are the risks of investing in NHTC?

Claude: Negative operating cash flow of -$6.0M annually indicates company is burning cash at unsustainable rate. Revenue declining 7.4% YoY with operating losses widening, suggesting structural profitability issues.

What is NHTC's revenue and growth?

NATURAL HEALTH TRENDS CORP reported revenue of $39.8M.

Does NHTC pay dividends?

NATURAL HEALTH TRENDS CORP pays dividends, with $9.2M distributed to shareholders in the trailing twelve months.

Where can I find NHTC SEC filings?

Official SEC filings for NATURAL HEALTH TRENDS CORP (CIK: 0000912061) including 10-K, 10-Q, and 8-K reports are available on SEC EDGAR.

What is NHTC's EPS?

NATURAL HEALTH TRENDS CORP has a diluted EPS of $-0.08.

How is the AI analysis conducted?

Two independent AI systems — Claude (Anthropic) and ChatGPT (OpenAI) — analyze SEC EDGAR filings including 10-K annual reports and 10-Q quarterly reports. Each AI evaluates financial health, profitability ratios, balance sheet strength, and growth metrics. The combined rating reflects both perspectives for balanced insights.

Is NHTC a good stock to buy right now?

Based on our AI fundamental analysis in April 2026, NATURAL HEALTH TRENDS CORP has a STRONG SELL rating with 85% confidence. Review the strengths and risks sections above before making a decision. This is not investment advice.

Is NHTC stock overvalued or undervalued?

Valuation metrics for NHTC: ROE of -3.8% (sector avg: 15%), net margin of -2.2% (sector avg: 12%). Compare these metrics with sector averages to assess valuation.

Should I buy NHTC stock in 2026?

Our dual AI analysis gives NATURAL HEALTH TRENDS CORP a combined STRONG SELL rating for 2026. Revenue is data pending, with profitability at or below sector average. Always conduct your own research.

What is NHTC's free cash flow?

NATURAL HEALTH TRENDS CORP's operating cash flow is $-6.0M, with capital expenditures of $68.0K. FCF margin is -15.2%.

How does NHTC compare to other Default stocks?

Vs Default sector averages: Net margin -2.2% (avg: 12%), ROE -3.8% (avg: 15%), current ratio 2.50 (avg: 1.8).

Disclaimer: This analysis is generated by Claude AI (Anthropic) and ChatGPT (OpenAI) based on publicly available SEC EDGAR filings. It does not include stock price data and should not be considered financial advice. All fundamental data is sourced from SEC public domain filings. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.
Data Source: SEC EDGAR | Analysis Date: Apr 13, 2026 | Data as of: 2025-12-31 | Powered by Claude AI